Patents Assigned to Lysoway Therapeutics, Inc.
  • Piperazine derivatives as TRPML modulators
    Patent number: 10851084
    Abstract: The new piperazine derivatives are modulators of TRPML and are useful in treating disorders related to TRPML activities such as lysosome storage diseases, muscular dystrophy, age-related common neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS) related diseases, and ageing.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: December 1, 2020
    Assignee: Lysoway Therapeutics, Inc.
    Inventor: Congxin Liang